Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adacel versus Quadracel fifth-dose booster study in children aged 4 to 6 years
2015-005589-43Phase 2
- Sponsor
- Sanofi
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of acellular pertussis vaccine and Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis and 1 more (2 arms), sponsored by Sanofi. Primary endpoint: Expected response levels for diphtheria and tetanus.
02
Drugs
acellular pertussis vaccineBordetella pertussis toxoid antigen (glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussispoliomyelitis
Beyond the preview
Go deeper on 2015-005589-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005589-43.